Overall Technical outlook

Price Summary

On 2025-10-17, CONCORDBIO's stock started at 1532.9, reached a high of 1548.7, fell to 1507.5, and ended -0.13% down at 1530.9, with 54150 shares traded.
Over the past 52 weeks, the stock reached a maximum price of 2345.6 and a minimum price of 1386.7.
Analysts expect the price of CONCORDBIO to vary between 1600.0 and 1970.0, with an average expected price near 1861.6666.

Technicals

Support and Resistance: The price currently sits at 1530.9, finding support at 1511.1 and resistance at 1604.1. These levels define a range for Concord Biotech Limited where the price may move, with 1511.1 offering a base and 1604.1 limiting upward momentum.
CONCORDBIO supportResistance 608982
Support/Resistance for CONCORDBIO


Aroon: The AROON is in a neutral stance, with no clear signals for movement up or down. This neutral position indicates a potential period of consolidation or uncertainty in the market.
CONCORDBIO aroon 608982
Aroon chart for Concord Biotech Limited


Bol. Bands: The current reading of the BOLL BANDS is neutral for CONCORDBIO, with no clear signals for an upward or downward trend. This indicates that the market may be in a state of uncertainty, with no dominant force driving the direction.
CONCORDBIO bbands 608982
Bolinger Bands chart for Concord Biotech Limited


Parabolic SAR: The PSAR continues its bearish trend for Concord Biotech Limited, setting a resistance level that could hinder upward momentum. This resistance suggests that the market may face challenges in breaking higher, reflecting persistent bearish sentiment.
CONCORDBIO psar 608982
Parabolic Stop and Reverse chart for Concord Biotech Limited


Stochastic: With the K-line above the D-line and below 20 on the stochastic indicator, a bullish move is likely on the horizon. This configuration suggests that the market could be starting to recover from a low point, possibly leading to an upward trend. Investors might interpret this as a signal to position for gains.
CONCORDBIO stoch 608982
Stochastic chart for Concord Biotech Limited


Tripple Moving Agerage: A bullish trend is indicated by the alignment of the 20-50-100 period moving averages, though the slopes of the faster averages hint at a potential reversal. The weakening momentum in the shorter-term averages suggests that the current trend may not hold, signaling the possibility of an upcoming change in direction for CONCORDBIO.
CONCORDBIO trippleSMA 608982
Tripple SMA chart for Concord Biotech Limited


When evaluating a company's technical indicators like price trends and trading volume, it's important to also assess its fundamentals. Key factors include the company's profitability, growth rate, and financial stability. Furthermore, considering the industry within which the company operates provides additional context, as factors like competition and market demand can affect performance. By combining this analysis, you can make more informed judgments about the company's future prospects.